Invitation to presentation in connection with EQL Pharma's year-end report, fourth quarter, 2025/26
EQL Pharma AB (publ) will publish its year-end report for the fourth quarter, 2025/26, on Friday, May 8th.
At 10.00 (CET) 8th May, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the year-end report. After the presentation, there is an opportunity to ask questions for those who participate.
Use the following link to access the virtual meeting: https://tinyurl.com/4h7x4yxn
Date and time
May 8th, 2026, at 10.00 (CET) the presentation starts. Time required for presentation and subsequent question time is estimated at a maximum 1 hour.
Make sure you are able to attend the video conference by logging in shortly before the start of the conference.
For more information contact:
Axel Schörling,
CEO & President EQL Pharma AB (publ)
Phone: +46 (0) 76 317 90 60
E-mail: axel.schorling@eqlpharma.com
Web: www.eqlpharma.com
Bifogade filer